BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

BioPharm America™ 2014 Press Releases

September 8, 2014BioPharm America™ 2014 leads off with Fierce 15 Announcement and Keynote Address featuring Chief Scientific Officer from Sanofi The seventh annual BioPharm America international life science partnering conference will kick off in a less than two weeks, September 22–24, at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The highly reputable life science partnering event will draw biotech and pharma executives from around the world to identify and enter into strategic r...  more ►

August 19, 2014Renewed investor appetite in biotech innovation means strong attendance expected at BioPharm America™ 2014 The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event is a big draw for pharma and investors who want to access innovative new potential therapies and cures brought by international biotech companies. "Today is a great time...  more ►

May 20, 2014Collaborative models and IPO window are hot topics at BioPharm America™ 2014 program The seventh annual BioPharm America international life science partnering conference will be held September 22–24 at Boston Marriott Copley Place in the center of Boston's historic Back Bay. The event brings together industry thought leaders and high level executives in the biopharma dealmaking arena to collaborate on and discuss relevant trends and topics. Several i...  more ►

April 15, 2014BioPharm America™ 2014 returns to Boston's Copley Place and a celebration of the FierceBiotech Fierce 15 The seventh annual BioPharm America international life science partnering conference will be held at Boston Marriott Copley Place in the center of Boston's historic Back Bay. Produced by EBD Group in collaboration with the Massachusetts Biotechnology Council (MassBio), the September 22–24 event will bring the global life science industry to Boston to facilitate strategic ...  more ►


partnering360® Blog

September 21, 2014 European biotech IPOs are slow but steady 2014 has been a strong year for US biotech IPOs, and the venture community has been taking on more risky upstart endeavors with flexible deal terms. According to a September 18 Financial Times article, the Nasdaq biotech index is on the rise again, up 20 percent since January of this year. IPO... more ►

September 19, 2014 Who can you meet next week at BioPharm America™? Next week, 900 plus Pharmaceutical professionals, Innovators and investors will meet in Boston for the BioPharma America ™ event.  With the power of partneringONE®, these companies will be able to meet and form strategic relationships that will move the industry forward. Here are just a few of... more ►

September 17, 2014 FierceBiotech’s 2014 Fierce 15 winners to be announced live at BioPharm America™ FierceBiotech’s annual list of the Fierce 15 involves a hunt for the biggest ideas in biotech, the most daring characters in biopharma, and entrepreneurs doing things that haven’t been done before. The result is fifteen privately held drug developers or platform biotechs with the potential... more ►

September 16, 2014 Innovation at Sanofi Sanofi looks for innovation in it’s drug portfolio in a variety of places – from the acquisitions they’ve made in their business to partnerships with venture capital, biotech and Pharma.  In a recent article at Insight, Gary J. Nabel, Senior VP, CSO and deputy to the President for... more ►

September 11, 2014 New therapeutic development models build researchers’ commercialization savvy Guest post from David Altman, Technology & Innovation Development Office, Boston Children’s Hospital Academic researchers and physician innovators are great at making research discoveries and developing inventions at an early stage. But if you were to fund them to turn their research... more ►



partnering360:Insight Latest headlines from partnering360:Insight

September 17, 2014 Vertex builds out BD group with sharp focus on in-licensing Both at BioPharm America™ in Boston and BIO-Europe® in Frankfurt, Vertex is on the hunt for research to late-stage development opportunities to further strengthen its pipeline through collaborations, part of a strategic shift meant to complement the ongoing internal research and development programs. more ►

September 9, 2014 Flagship Ventures explores the pharma innovation supply chain The care and feeding of the innovation supply chain is a primary focus for Flagship Ventures. While other venture capital firms are focusing on new financing options, this venture firm takes the more holistic approach of fostering innovation among early, disruptive platform companies—many of which they’ve created from scratch in-house—and forging relationships with larger firms that can take the platforms all the way to commercialization. more ►

September 5, 2014 Sanofi finds innovation in many places With ten therapeutic areas plus animal health, Sanofi’s R&D portfolio is well balanced to build upon the strengths of each of the franchises in its portfolio and to capitalize on innovative ideas and projects outside the company. more ►

August 13, 2014 Gene, stem cell therapies bring new players to partnering The next generation of therapies built upon the science of stem cells and genetics will require new types of partnerships. If there is promise that these technologies can redefine how we understand and treat disease, there is already a certainty that the alliances and partnerships required to bring these therapies to patients are also beyond traditional models for commercialization. more ►

August 1, 2014 J&J: “Innovation delivers growth and growth sustains our innovation” "What we are really trying to accomplish is building more than a financial relationship. We are interested in truly finding a way to get to the outcomes. We want to keep our partners intimately involved in a pursuit of truth, in understanding what this science means in the lives of patients who might benefit the most from it. It is this dialogue we are after." more ►



Arrow Up


 
 
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2014 EBD Group, Inc.
Privacy Policy
Terms of Use
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America